FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 8250485 · Received January 15, 2019

Report

Report Number
2124215-2019-00415
Event Type
Injury
Date Received
January 15, 2019
Date of Event
March 1, 2018
Report Date
January 15, 2019
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
LWS
UDI-DI
00802526531125
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) DEFIBRILLATION LEAD EXHIBITED SHOCK IMPEDANCE MEASUREMENTS OF LESS THAN 20 OHMS, PACING IMPEDANCE MEASUREMENTS OF LESS THAN 200 OHMS, LOSS OF CAPTURE, POCKET STIMULATION WITH PACING, NOISE, OVERSENSING, INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP), AND INAPPROPRIATE SHOCKS. A SURGICAL REVISION WAS PERFORMED, AND THIS LEAD WAS SURGICALLY ABANDONED AND REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
43095 ENDOTAK RELIANCE IMPLANTABLE LEAD LWS BOSTON SCIENTIFIC CORPORATION 0157 00802526531125

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| L| R